Table Of Contents:
1. How to Develop and Maintain a Hazardous Drug List
2. Summary of Educational Offerings Provided by Compounding Support Companies in 2019
3. Compounding for Patients with Polycystic Ovarian Syndrome (Stein-Leventhal Syndrome)
4. Topical Treatment of Cutaneous Leishmaniasis in Israel, Part 1
5. Can We Fix It?
6. Summary of Quality-Control Testing for Sterile and Nonsterile Compounded Preparations, Part 1: Physical and Chemical Testing
7. Basics of Sterile Compounding: Vehicles Used in Sterile Compounding
8. Calculations
9. Aripiprazole 1 mg/mL in Methylcellulose 1% Syrup Oral Suspension
10. Chloroquine Phosphate 15 mg/mL in SyrSpend SF pH4
11. Clopidogrel 5 mg/mL in a Sugar-Free Syrup
12. Flunisolide Nasal Spray
13. Mebeverine Hydrochloride 10 mg/mL in SyrSpend SF pH4
14. Methotrexate 2-mg/mL Oral Solution
15. Sildenafil 2.5 mg/mL in Ora-Plus:Ora-Sweet
16. Valsartan 16-mg/mL Oral Suspension
17. Evaluation of the Quality of Sterile Compounding Videos Available on the YouTube Video-sharing Website
18. Trends of Extemporaneous Drug Prescription in Latvia in 2017
19. Compounding and Comparative Study of a Superior, Faster, and More Adaptable Lidocaine Dental Gel Formulation
20. An Exploratory Study of Suboxone (Buprenorphine/Naloxone) Film Splitting: Cutting Methods, Content Uniformity, and Stability